Hybrigenics S.A. · Paris France
Company Description
View Hybrigenics S.A. Locations On A US Map
This link will open in a new window
This link will open in a new window Hybrigenics wants to open a new pathway towards the fight against cancer. Established in 1997, the drug discovery company zeroes in on new drug targets and therapeutic biological components with the help of its computer programs involving protein sequencing and other high tech chemical screening techniques. What separates it from other drug researching companies is its Laboratory Information Management System (LIMS), a product that commercializes its library screening and navigating capabilities regarding DNA and other related biological sequencing. With its headquarters in Paris, Hybrigenics also owns Semaia BV, a subsidiary located in the Netherlands, and an additional office in the US. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Hybrigenics S.A. Financials
| Company Type | Private Single Location |
| Fiscal Year-End | December |
| Annual Sales (mil.) | $3.6 |
| Employees | 46 |
Hybrigenics S.A. Executives
10 executives listed for Hybrigenics S.A.'s Paris, location.
| Title | Name & Bio | Contact |
| Chairman | Daan Ellens | Network |
| CEO | Rémi Delansorne | Network |
| Senior Director, Operations | Didier Petiteville | Network |
Competition
Competitive Landscape for Hybrigenics S.A.
Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior products. Large companies have economies of scale in manufacturing and R&D. Small companies can compete successfully by specializing in a particular market segment, or through technical innovation. To read the full description, subscribe now.Top Hybrigenics S.A. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!